Dai Ichi Life Insurance Company Ltd raised its holdings in Anthem, Inc. (NYSE:ANTM) by 114.2% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 28,011 shares of the company’s stock after acquiring an additional 14,931 shares during the quarter. Dai Ichi Life Insurance Company Ltd’s holdings in Anthem were worth $5,270,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in ANTM. DekaBank Deutsche Girozentrale bought a new position in Anthem in the first quarter valued at approximately $41,017,000. Boston Partners boosted its stake in Anthem by 112.6% in the first quarter. Boston Partners now owns 3,895,863 shares of the company’s stock valued at $644,298,000 after acquiring an additional 2,063,562 shares during the last quarter. US Bancorp DE boosted its stake in Anthem by 4.1% in the first quarter. US Bancorp DE now owns 55,606 shares of the company’s stock valued at $9,196,000 after acquiring an additional 2,176 shares during the last quarter. Strategic Advisors LLC bought a new position in Anthem in the first quarter valued at approximately $567,000. Finally, Point View Wealth Management Inc. boosted its stake in Anthem by 5.0% in the first quarter. Point View Wealth Management Inc. now owns 14,788 shares of the company’s stock valued at $2,446,000 after acquiring an additional 701 shares during the last quarter. 87.69% of the stock is currently owned by hedge funds and other institutional investors.
In related news, insider Joseph Swedish sold 21,125 shares of the firm’s stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $197.00, for a total transaction of $4,161,625.00. Following the transaction, the insider now directly owns 87,668 shares of the company’s stock, valued at $17,270,596. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Thomas C. Zielinski sold 9,127 shares of the firm’s stock in a transaction dated Thursday, August 10th. The shares were sold at an average price of $191.25, for a total transaction of $1,745,538.75. Following the transaction, the executive vice president now directly owns 26,571 shares in the company, valued at $5,081,703.75. The disclosure for this sale can be found here. Insiders sold 30,776 shares of company stock worth $6,007,143 over the last ninety days. Insiders own 0.36% of the company’s stock.
Shares of Anthem, Inc. (NYSE:ANTM) traded up 0.48% during midday trading on Monday, reaching $194.78. 161,353 shares of the company’s stock traded hands. The company has a 50 day moving average of $191.62 and a 200 day moving average of $181.10. The firm has a market cap of $51.15 billion, a PE ratio of 18.42 and a beta of 0.70. Anthem, Inc. has a 52-week low of $114.85 and a 52-week high of $198.98.
Anthem (NYSE:ANTM) last released its quarterly earnings data on Wednesday, July 26th. The company reported $3.37 earnings per share for the quarter, beating analysts’ consensus estimates of $3.23 by $0.14. Anthem had a net margin of 3.24% and a return on equity of 12.93%. The firm had revenue of $22.20 billion for the quarter, compared to analyst estimates of $22.25 billion. During the same period last year, the firm earned $3.33 earnings per share. The business’s quarterly revenue was up 4.3% compared to the same quarter last year. On average, equities analysts predict that Anthem, Inc. will post $11.83 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be paid a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.44%. This is a positive change from Anthem’s previous quarterly dividend of $0.65. The ex-dividend date of this dividend is Thursday, September 7th. Anthem’s dividend payout ratio (DPR) is 26.52%.
ANTM has been the topic of a number of recent research reports. Morgan Stanley initiated coverage on shares of Anthem in a research note on Tuesday, June 6th. They issued an “equal weight” rating and a $196.00 price objective on the stock. Citigroup Inc. reaffirmed a “buy” rating and issued a $205.00 price objective on shares of Anthem in a research note on Wednesday, June 28th. Credit Suisse Group initiated coverage on shares of Anthem in a research note on Wednesday, July 12th. They issued a “neutral” rating and a $195.00 price objective on the stock. Deutsche Bank AG raised their price objective on shares of Anthem from $173.00 to $185.00 and gave the company a “hold” rating in a research note on Thursday, July 13th. Finally, Bank of America Corporation raised their price objective on shares of Anthem from $224.00 to $228.00 and gave the company a “buy” rating in a research note on Friday, July 14th. Nine equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Anthem presently has a consensus rating of “Buy” and an average price target of $183.94.
Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.
Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem, Inc. (NYSE:ANTM).
Receive News & Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.